Sharp cuts in cancer drug prices expose excessive pricing, say health experts
What happened
According to a report by The Hindu, health experts say sharp cuts in the price of cancer drugs expose excessive pricing. The full article text was not available, so the specific drugs, size of the cuts and experts' reasoning are not covered here.
When it started
The topic was first picked up on 28 October 2026. The source did not give the dates on which the price cuts took effect.
How it spread
The story is based on the headline and summary of a Google News link to The Hindu. The mechanism behind the price cuts, the companies or regulators involved and any official statements were not available.
Why it matters
The claim that cancer drug prices were excessive matters for patient access and healthcare costs in India. It is the view of health experts as reported by The Hindu, and more detail is needed to assess it.